Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients
NCT ID: NCT06080737
Last Updated: 2025-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2024-05-03
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)
NCT06141837
Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit
NCT03046082
Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France
NCT04420286
NOSOcomial COVID-19 in ICU (NOSOCOVID)
NCT04659356
Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection
NCT04849585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard oxygen group
telephone interview comprising a quality of life questionnaire
quality of life questionnaire
telephone interview to assess mortality and quality of life in the population included in a trial
awake prone group
telephone interview comprising a quality of life questionnaire
quality of life questionnaire
telephone interview to assess mortality and quality of life in the population included in a trial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
quality of life questionnaire
telephone interview to assess mortality and quality of life in the population included in a trial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients alive at D28
* No opposition to participate in the research which evaluates mortality and quality of life by telephone interview.
Exclusion Criteria
* Withdrawal of consent from randomized meta-trial by patient
* Vulnerable person: safeguard of justice, curatorship, or guardianship
* Patients refusing to answer telephone questionnaire.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
university hospital Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DR 230170 - Long-term APP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.